Latest Insider Transactions at Intuitive Surgical Inc (ISRG)
This section provides a real-time view of insider transactions for Intuitive Surgical Inc (ISRG). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of INTUITIVE SURGICAL INC to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of INTUITIVE SURGICAL INC's insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Apr 22
2022
|
Alan J Levy Director |
BUY
Exercise of conversion of derivative security
|
Direct |
555
+2.19%
|
-
|
|
Apr 22
2022
|
Amal M Johnson |
BUY
Exercise of conversion of derivative security
|
Direct |
555
+4.71%
|
-
|
|
Apr 22
2022
|
Amy L Ladd Director |
BUY
Exercise of conversion of derivative security
|
Direct |
555
+29.6%
|
-
|
|
Apr 22
2022
|
Craig H Barratt Director |
BUY
Exercise of conversion of derivative security
|
Indirect |
753
+2.96%
|
-
|
|
Apr 22
2022
|
Don R Kania Director |
BUY
Exercise of conversion of derivative security
|
Direct |
555
+16.61%
|
-
|
|
Apr 22
2022
|
Jami K Nachtsheim Director |
BUY
Exercise of conversion of derivative security
|
Direct |
555
+10.81%
|
-
|
|
Apr 22
2022
|
Joseph C Beery Director |
BUY
Exercise of conversion of derivative security
|
Direct |
555
+29.6%
|
-
|
|
Apr 22
2022
|
Keith R Leonard Director |
BUY
Exercise of conversion of derivative security
|
Direct |
555
+15.18%
|
-
|
|
Apr 22
2022
|
Mark J Rubash Director |
BUY
Exercise of conversion of derivative security
|
Direct |
555
+3.57%
|
-
|
|
Apr 22
2022
|
Monica P Reed Director |
BUY
Exercise of conversion of derivative security
|
Direct |
555
+50.0%
|
-
|
|
Mar 01
2022
|
Myriam Curet EVP & Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
2,000
-84.71%
|
$578,000
$289.96 P/Share
|
|
Feb 28
2022
|
Gary S Guthart CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
1,918
-19.3%
|
$556,220
$290.33 P/Share
|
|
Feb 28
2022
|
Gary S Guthart CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
3,867
+28.01%
|
-
|
|
Feb 28
2022
|
David J. Rosa President |
SELL
Payment of exercise price or tax liability
|
Direct |
1,119
-0.95%
|
$324,510
$290.33 P/Share
|
|
Feb 28
2022
|
David J. Rosa President |
BUY
Exercise of conversion of derivative security
|
Direct |
2,256
+1.88%
|
-
|
|
Feb 28
2022
|
Myriam Curet EVP & Chief Medical Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
1,119
-32.16%
|
$324,510
$290.33 P/Share
|
|
Feb 28
2022
|
Myriam Curet EVP & Chief Medical Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
2,256
+39.33%
|
-
|
|
Feb 28
2022
|
Robert De Santis EVP & Chief Strategy & Corp Op |
SELL
Payment of exercise price or tax liability
|
Direct |
1,008
-13.69%
|
$292,320
$290.33 P/Share
|
|
Feb 28
2022
|
Robert De Santis EVP & Chief Strategy & Corp Op |
BUY
Exercise of conversion of derivative security
|
Direct |
2,175
+22.8%
|
-
|
|
Feb 28
2022
|
Reiter Kara Andersen Sr VP General Counsel & CCO |
SELL
Payment of exercise price or tax liability
|
Direct |
560
-3.01%
|
$162,400
$290.33 P/Share
|
|
Feb 28
2022
|
Reiter Kara Andersen Sr VP General Counsel & CCO |
BUY
Exercise of conversion of derivative security
|
Direct |
1,128
+5.71%
|
-
|
|
Feb 28
2022
|
Jamie Samath |
SELL
Payment of exercise price or tax liability
|
Direct |
539
-13.63%
|
$156,310
$290.33 P/Share
|
|
Feb 28
2022
|
Jamie Samath |
BUY
Exercise of conversion of derivative security
|
Direct |
1,257
+24.12%
|
-
|
|
Feb 28
2022
|
Fredrik Widman VP Corporate Controller |
SELL
Payment of exercise price or tax liability
|
Direct |
295
-9.9%
|
$85,550
$290.33 P/Share
|
|
Feb 28
2022
|
Fredrik Widman VP Corporate Controller |
BUY
Exercise of conversion of derivative security
|
Direct |
852
+22.23%
|
-
|
|
Feb 28
2022
|
Henry L Charlton SVP & Chief Commercial and Mkt |
SELL
Payment of exercise price or tax liability
|
Direct |
654
-3.67%
|
$189,660
$290.33 P/Share
|
|
Feb 28
2022
|
Henry L Charlton SVP & Chief Commercial and Mkt |
BUY
Exercise of conversion of derivative security
|
Direct |
1,449
+7.52%
|
-
|
|
Feb 28
2022
|
Marshall Mohr Executive VP Global Business S |
SELL
Payment of exercise price or tax liability
|
Direct |
1,119
-19.8%
|
$324,510
$290.33 P/Share
|
|
Feb 28
2022
|
Marshall Mohr Executive VP Global Business S |
BUY
Exercise of conversion of derivative security
|
Direct |
2,256
+28.53%
|
-
|
|
Feb 26
2022
|
Gary S Guthart CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
1,503
-19.85%
|
$440,379
$293.51 P/Share
|
|
Feb 26
2022
|
Gary S Guthart CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
3,030
+28.58%
|
-
|
|
Feb 26
2022
|
David J. Rosa President |
SELL
Payment of exercise price or tax liability
|
Direct |
850
-0.73%
|
$249,050
$293.51 P/Share
|
|
Feb 26
2022
|
David J. Rosa President |
BUY
Exercise of conversion of derivative security
|
Direct |
1,713
+1.45%
|
-
|
|
Feb 26
2022
|
Myriam Curet EVP & Chief Medical Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
850
-40.98%
|
$249,050
$293.51 P/Share
|
|
Feb 26
2022
|
Myriam Curet EVP & Chief Medical Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
1,713
+45.23%
|
-
|
|
Feb 26
2022
|
Robert De Santis EVP & Chief Strategy & Corp Op |
SELL
Payment of exercise price or tax liability
|
Direct |
737
-12.44%
|
$215,941
$293.51 P/Share
|
|
Feb 26
2022
|
Robert De Santis EVP & Chief Strategy & Corp Op |
BUY
Exercise of conversion of derivative security
|
Direct |
1,590
+21.16%
|
-
|
|
Feb 26
2022
|
Reiter Kara Andersen Sr VP General Counsel & CCO |
SELL
Payment of exercise price or tax liability
|
Direct |
702
-3.86%
|
$205,686
$293.51 P/Share
|
|
Feb 26
2022
|
Reiter Kara Andersen Sr VP General Counsel & CCO |
BUY
Exercise of conversion of derivative security
|
Direct |
1,467
+7.46%
|
-
|
|
Feb 26
2022
|
Jamie Samath |
SELL
Payment of exercise price or tax liability
|
Direct |
445
-14.16%
|
$130,385
$293.51 P/Share
|
|
Feb 26
2022
|
Jamie Samath |
BUY
Exercise of conversion of derivative security
|
Direct |
1,284
+29.01%
|
-
|
|
Feb 26
2022
|
Fredrik Widman VP Corporate Controller |
SELL
Payment of exercise price or tax liability
|
Direct |
211
-9.02%
|
$61,823
$293.51 P/Share
|
|
Feb 26
2022
|
Fredrik Widman VP Corporate Controller |
BUY
Exercise of conversion of derivative security
|
Direct |
609
+20.65%
|
-
|
|
Feb 26
2022
|
Henry L Charlton SVP & Chief Commercial and Mkt |
SELL
Payment of exercise price or tax liability
|
Direct |
580
-3.42%
|
$169,940
$293.51 P/Share
|
|
Feb 26
2022
|
Henry L Charlton SVP & Chief Commercial and Mkt |
BUY
Exercise of conversion of derivative security
|
Direct |
1,284
+7.05%
|
-
|
|
Feb 26
2022
|
Marshall Mohr Executive VP Global Business S |
SELL
Payment of exercise price or tax liability
|
Direct |
850
-20.02%
|
$249,050
$293.51 P/Share
|
|
Feb 26
2022
|
Marshall Mohr Executive VP Global Business S |
BUY
Exercise of conversion of derivative security
|
Direct |
1,713
+28.75%
|
-
|
|
Feb 16
2022
|
Myriam Curet EVP & Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
2,478
-87.28%
|
$716,142
$289.0 P/Share
|
|
Feb 15
2022
|
Myriam Curet EVP & Chief Medical Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
2,271
-32.58%
|
$656,319
$289.31 P/Share
|
|
Feb 15
2022
|
Myriam Curet EVP & Chief Medical Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
4,749
+39.61%
|
-
|